Research identifies key role of CXCL9 cytokine in age-related chronic inflammation

NewsGuard 100/100 Score

An inflammatory-aging clock called developed by Stanford University School of Medicine and the Buck Institute for Research on Aging can predict how strong your immune system will be in 10 years, when you'll become frail or whether you may develop cardiovascular diseases a few years down the road.

The research, published in the journal Nature Aging, shows how the inflammatory-aging clock or iAge predicts a person's immunological decline and the risk for incurring age-related diseases and frailty.

Good and bad inflammation

The immune system is responsible for protecting us from foreign invaders such as bacteria, viruses, fungi, and toxic chemicals. The immune system is a group of cells that work together to counter threats to health, such as injuries and pathogen attacks. In response to a threat, it mounts a quick, intense, localized, and short-term response, called acute inflammation.

Good inflammation is a natural response of the immune system to invaders or infection. It emerges and goes away in a few days. However, chronic inflammation occurs with aging. As people grow older, low-grade inflammation occurs, causing organ damage and increases susceptibility to chronic diseases such as heart attacks, strokes, cancer, neurodegeneration, and immunity.

To date, there are no accurate assessment criteria to determine a person's inflammatory status that could predict impending diseases and clinical issues.

Inflammatory aging clock

The inflammatory aging clock (iAge) is more accurate than biological age in predicting the immune system's strength, how soon a person becomes weak or undiagnosed chronic diseases.

This new method could help doctors and clinicians determine an older person's risk for diseases that could take a toll on their overall health. The study also shed light on why some people, though the same age, are not similar in their health status.

The differing rates at which the decline of the immune system can explain why some older adults are disease-prone at the same age while others are perfectly healthy.

To arrive at the study findings and the accurate inflammatory aging clock, the team collected blood immunome from 1,001 individuals between the ages of 8 and 96. They developed a deep-learning tool based on the patterns of systemic age-related inflammation. Called iAge, the resulting inflammatory aging clock could help predict multimorbidity and other conditions related to aging.

Chemokines and chronic illness

The researchers noted that the most potent contributor to iAge was CXCL9, a chemokine involved in cardiac aging, poor vascular function, and adverse cardiac remodeling. The CXCL9 is secreted by immune cells to attract other immune cells to the site of injury or infection. At the age of 60, the levels of this chemokine start to increase.

They later found that higher levels of CXCL9 are tied to an elevated risk for strokes, kidney failure, and heart attacks. Apart from this, CXCL9 levels are also linked to the hardening of arterial walls and excessive thickness of the heart's left ventricle. All these are predisposing factors to cardiovascular disease.

"In conclusion, we identify a key role of CXCL9 in age-related chronic inflammation and derive a metric for multimorbidity that can be utilized for the early detection of age-related clinical phenotypes," the team concluded in the study.

When the team performed experiments on tissue from mice and human cells, they found that decreasing CXCL9 levels have restored youthful endothelia-cell function. The findings suggest that chemokine is directly related to cell dysfunction. Thus, inhibiting CXCL9 can be a promising treatment to reduce the risk of cardiovascular illness.

In a nutshell, the team concluded that the inflammatory aging clock's ability to detect accelerated cardiovascular aging could help doctors treat aging patients. Aside from that, it can be used to detect the likelihood of developing chronic diseases early, paving the way for timely treatment.

Source:

 

Source:
Journal reference:
Angela Betsaida B. Laguipo

Written by

Angela Betsaida B. Laguipo

Angela is a nurse by profession and a writer by heart. She graduated with honors (Cum Laude) for her Bachelor of Nursing degree at the University of Baguio, Philippines. She is currently completing her Master's Degree where she specialized in Maternal and Child Nursing and worked as a clinical instructor and educator in the School of Nursing at the University of Baguio.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Laguipo, Angela. (2021, July 14). Research identifies key role of CXCL9 cytokine in age-related chronic inflammation. News-Medical. Retrieved on May 18, 2024 from https://www.news-medical.net/news/20210714/Research-identifies-key-role-of-CXCL9-cytokine-in-age-related-chronic-inflammation.aspx.

  • MLA

    Laguipo, Angela. "Research identifies key role of CXCL9 cytokine in age-related chronic inflammation". News-Medical. 18 May 2024. <https://www.news-medical.net/news/20210714/Research-identifies-key-role-of-CXCL9-cytokine-in-age-related-chronic-inflammation.aspx>.

  • Chicago

    Laguipo, Angela. "Research identifies key role of CXCL9 cytokine in age-related chronic inflammation". News-Medical. https://www.news-medical.net/news/20210714/Research-identifies-key-role-of-CXCL9-cytokine-in-age-related-chronic-inflammation.aspx. (accessed May 18, 2024).

  • Harvard

    Laguipo, Angela. 2021. Research identifies key role of CXCL9 cytokine in age-related chronic inflammation. News-Medical, viewed 18 May 2024, https://www.news-medical.net/news/20210714/Research-identifies-key-role-of-CXCL9-cytokine-in-age-related-chronic-inflammation.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study uncovers 17 genes driving clonal hematopoiesis and links to aging and disease